Doctors tested a common drug on COVID. The results are stunning
Short excerpt below. Click through to read at the original source.
Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential against other respiratory infections. With its unique triple-action benefits, it could serve as a powerful and accessible treatment worldwide.